Okun Andrew 4

4 · PERKINELMER INC · Filed Dec 16, 2022

Form 4

Period: 2022-12-15

VP & Chief Accounting Officer

Transactions

Exercise/Conversion
Common Stock
2022-12-15$92.09/sh+4,800$442,032→ 11,191 total
Exercise/Conversion
Common Stock
2022-12-15$96.06/sh+3,350$321,801→ 14,541 total
Sale
Common Stock
2022-12-15$140.82/sh−4,995$703,396→ 9,546 total
Sale
Common Stock
2022-12-15$141.21/sh−3,155$445,518→ 6,391 total
Exercise/Conversion
NQ Stock Option (right to buy)
2022-12-15−4,800→ 0 total
Exercise: $92.09Exp: 2026-02-05→ Common Stock (4,800 underlying)
Exercise/Conversion
NQ Stock Option (right to buy)
2022-12-15−3,350→ 1,675 total
Exercise: $96.06Exp: 2027-01-30→ Common Stock (3,350 underlying)

Holdings

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on November 15, 2022.
[F2]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.04 to $141.01. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
[F3]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $141.04 to $141.77. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
[F4]This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
[F5]This option became exercisable in three equal annual installments beginning on January 30, 2021, which was the first anniversary of the date on which the option was granted.

Documents

1 file